CEO of Dr Reddy's Laboratories, Erez Israeli believes his company's affordable medicines benefit the U.S. market and will be ...

Dr Reddy’s Laboratories reports 2% increase in net profit, attributing growth to new acquisitions and product launches.

The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.

Dr Reddy's Laboratories shares dropped nearly 7% on Friday after the company reported a slight increase in net profit for the ...

Dr. Reddy’s Laboratories shares fell by 6.2%, hitting an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, ...

Shares of Dr Reddy's Laboratories Ltd tumbled more than 6.65 per cent to Rs 1,203.60 on Friday, with its total market capitalisation slipping below Rs 1 lakh crore mark.

In early trade, Nifty rose 0.31 per cent to 23,277, while the 30-stock Sensex advanced 0.31 per cent to 76,765. Seven out of the 12 sectors on the NSE advanced, with Nifty Metal and Nifty Oil and gas ...

By Bharath Rajeswaran and Indranil Sarkar (Reuters) -Indian shares gave up opening gains to inch lower on Friday, as worries ...

PayTM(Rs. 673.34 crore), HDFC Bank(Rs. 628.41 crore), Aegis Logistics(Rs. 548.06 crore), Dr. Reddys(Rs. 508.47 crore), Kalyan ...

Quarterly Net Profit at Rs. 849.40 crore in December 2024 up 78.75% from Rs. 475.20 crore in December 2023. EBITDA stands at ...

Retail and banking stocks rose 0.5 per cent and 0.7 per cent, respectively. NEW DELHI: Mining stocks were trading lower on ...

Torrent Pharma, IndiGo parent InterGlobe Aviation, Godrej Consumer Products, JSW Steel, and Bank of India are among few of the key firms that will report Q3 results today. Track updates here ...